Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

NXF3 Activators

NXF3 Activators are a specialized set of chemical compounds that enhance the function of NXF3, a protein integral to the mRNA export mechanism in cells. These activators work by manipulating cellular pathways that indirectly increase the efficiency of NXF3-mediated export. For instance, Importazole targets proteins that regulate nuclear export and import, respectively, leading to a potential compensatory upregulation of NXF3 activity to maintain cellular export demands. Similarly, compounds like Bis(2,3-dibromopropyl) disulfide and Phenylarsine oxide chemically modify proteins within the nuclear export pathway, potentially enhancing the role of NXF3 as a secondary effect. This indirect activation strategy ensures that NXF3 continues to fulfill its role despite perturbations in related transport pathways.

Further supporting NXF3 activity, compounds such as Nucleoplasmin and Wheat germ agglutinin modify the nuclear environment by affecting chromatin structure and glycosylated proteins, respectively, which could shift mRNA export reliance toward NXF3. Additionally, Methotrexate and Geldanamycin indirectly promote NXF3 function by influencing nucleotide synthesis and protein chaperoning, underscoring the adaptability of NXF3 in response to broader metabolic changes. Agents like MLN4924 and Cycloheximide, which disrupt protein synthesis, may also inadvertently enhance NXF3's role in handling and exporting mRNA. Lastly, RG108, through transcriptional inhibition and epigenetic modulation, could necessitate heightened NXF3 activity to process and manage the cellular mRNA pool.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Phenylarsine oxide

637-03-6sc-3521
250 mg
$41.00
4
(1)

Phenylarsine oxide binds to vicinal dithiols and may modulate the activity of proteins involved in mRNA export, indirectly enhancing NXF3 activity by affecting the redox state of the nuclear export machinery.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate inhibits dihydrofolate reductase, leading to altered nucleotide synthesis and potentially increasing NXF3 activity to export aberrant mRNA transcripts for degradation.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to Hsp90 and can disrupt its function, indirectly enhancing NXF3 activity by affecting the chaperoning process of NXF3 complexes.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

MLN4924 inhibits NEDD8-activating enzyme, which could lead to stabilization of proteins involved in mRNA export and potentially enhance NXF3 activity.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis, which could indirectly increase NXF3 activity by reducing overall mRNA translation and increasing the need for mRNA export.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108 is a DNA methyltransferase inhibitor, potentially increasing the expression of genes involved in mRNA export, indirectly enhancing NXF3 activity.